NYSEAMERICAN:VTAK Catheter Precision (VTAK) Stock Price, News & Analysis $0.35 -0.01 (-2.53%) Closing price 02/21/2025 04:10 PM EasternExtended Trading$0.36 +0.01 (+3.17%) As of 02/21/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort Interest About Catheter Precision Stock (NYSEAMERICAN:VTAK) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Catheter Precision alerts:Sign Up Key Stats Today's Range$0.34▼$0.3750-Day Range N/A52-Week Range$0.31▼$8.40Volume132,234 shsAverage Volume140,430 shsMarket Capitalization$3.07 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCatheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina.Read More… Catheter Precision Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks22nd Percentile Overall ScoreVTAK MarketRank™: Catheter Precision scored higher than 22% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Catheter Precision. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Catheter Precision are expected to grow in the coming year, from ($8.90) to ($6.30) per share.Price to Book Value per Share RatioCatheter Precision has a P/B Ratio of 0.01. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Catheter Precision's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.09% of the float of Catheter Precision has been sold short.Short Interest Ratio / Days to CoverCatheter Precision has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Catheter Precision has recently decreased by 24.82%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCatheter Precision does not currently pay a dividend.Dividend GrowthCatheter Precision does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.09% of the float of Catheter Precision has been sold short.Short Interest Ratio / Days to CoverCatheter Precision has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Catheter Precision has recently decreased by 24.82%, indicating that investor sentiment is improving significantly. News and Social Media0.6 / 5News SentimentN/A MarketBeat Follows1 people have added Catheter Precision to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Catheter Precision insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1.00 in company stock.Percentage Held by InsidersOnly 1.35% of the stock of Catheter Precision is held by insiders.Percentage Held by InstitutionsOnly 20.34% of the stock of Catheter Precision is held by institutions.Read more about Catheter Precision's insider trading history. Receive VTAK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Catheter Precision and its competitors with MarketBeat's FREE daily newsletter. Email Address VTAK Stock News HeadlinesCatheter Precision to attend, participate in ISLAAFebruary 11, 2025 | markets.businessinsider.comCatheter Precision Inc. Engages PCG Advisory to Broaden Investor Relations StrategyFebruary 10, 2025 | globenewswire.comThe FED is losing the war on inflation It's no longer just a “guesstimate” – Inflation is indeed getting worse. And although we want to believe the Fed has a good grip on it, they don't. Right now, the suits over there are caught between a rock and a hard place. Either they watch as inflation grows, or they tear it down and send us into a full-blown recession. The kicker here is that neither of these are good for you. Whichever pill we end up with, prices will still climb higher as the value of the dollar sinks lower. The only real way out for the regular person is to increase your earning power. By increasing your income to match prices as they flare up… You’ll stay ahead of the impending doom we're running face-first into. And if you're looking for a strategy to help increase your income in 2025… I've got just the thing for you! You see, last year, I was able to grow a $10k model account to a little over $63k with 100 trade alerts But I changed my trading rules and more than doubled my results on those 100 published trades. I'm now calling them Warped Options…February 23, 2025 | WealthPress (Ad)Catheter Precision to Attend and Participate in the 13th Internation Symposium on Left Atrial AppendageFebruary 6, 2025 | globenewswire.comCatheter Precision, Inc. Announces The Closing of its Acquisition of PeriKard, LLCFebruary 4, 2025 | markets.businessinsider.comCatheter Precision awards stock options to top executivesFebruary 4, 2025 | msn.comCatheter Precision Approves Executive Stock Option PlanFebruary 4, 2025 | tipranks.comCatheter Precision, Inc. Announces The Closing of its Acquisition of PeriKard, LLCFebruary 4, 2025 | globenewswire.comSee More Headlines VTAK Stock Analysis - Frequently Asked Questions When did Catheter Precision's stock split? Catheter Precision shares reverse split before market open on Monday, July 15th 2024. The 1-10 reverse split was announced on Monday, July 15th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 15th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Who are Catheter Precision's major shareholders? Catheter Precision's top institutional investors include Warberg Asset Management LLC (3.51%). Insiders that own company stock include David A Jenkins and Martin J Colombatto. View institutional ownership trends. How do I buy shares of Catheter Precision? Shares of VTAK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Catheter Precision own? Based on aggregate information from My MarketBeat watchlists, some other companies that Catheter Precision investors own include ARMOUR Residential REIT (ARR), Jiuzi (JZXN), Windtree Therapeutics (WINT), AMC Entertainment (AMC), Sphere 3D (ANY), BioCardia (BCDA) and Chemomab Therapeutics (CMMB). Company Calendar Today2/23/2025Next Earnings (Estimated)4/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSEAMERICAN:VTAK CUSIPN/A CIK1716621 Webwww.catheterprecision.com Phone973-691-2000FaxN/AEmployees14Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-70,570,000.00 Net Margins-2,928.32% Pretax Margin-2,928.32% Return on Equity-69.90% Return on Assets-41.82% Debt Debt-to-Equity Ratio0.12 Current Ratio0.66 Quick Ratio0.65 Sales & Book Value Annual Sales$440,000.00 Price / Sales6.97 Cash FlowN/A Price / Cash FlowN/A Book Value$30.16 per share Price / Book0.01Miscellaneous Outstanding Shares8,840,000Free Float8,720,000Market Cap$3.07 million OptionableN/A Beta-0.34 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NYSEAMERICAN:VTAK) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catheter Precision, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catheter Precision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
